Genmab A/S (GMAB) Reports Q2 Net Sales of DARZALEX of $1.97B

Go back to Genmab A/S (GMAB) Reports Q2 Net Sales of DARZALEX of $1.97B
(NASDAQ: GMAB) Delayed: 31.25 +1.42 (4.76%)
Previous Close $29.83    52 Week High
Open $31.44    52 Week Low
Day High $31.79    P/E N/A 
Day Low $30.92    EPS
Volume 3,507,363